What a first day at the American College of Rheumatology (ACR) Conference! I heard that there are over 15,000 people here and they are from all over the world. I spent the morning volunteering at the Rheumatoid Patient Foundation (RPF) booth and then attended sessions in the afternoon. I met the wonderful people from the Arthritis National Research Foundation and Arthritis Introspective. The exhibit hall was overwhelming!
If you want to receive regular updates via Twitter, I’m @livingwra.
Here’s a list of topics I plan to write about over the next few weeks as I have time to process information.
- Pharma companies spend lots of money at conferences (and give free lattes).
- Personalized medicine based on genomics and autoantibody profiles may be in the future.
- Biomarkers for various various signaling pathways may help select targeted kinase inhibitors.
- Autoimmune antibody markers other than Rheumatoid Factor (RF) and Anti-CCP are being investigated in order to better predict RA.
- People with positive RF and Anti-CCP tests tend to have higher levels of inflammatory cytokines.
- The lung is being investigated as a possible site of RA initiation.
- Systemic inflammation in RA contributes to depression.
More updates tomorrow and details about our paper presentation on Tuesday to follow.